Stockreport

Assessing Sarepta Therapeutics (SRPT) Valuation After Early siRNA Trial Results Spark Share Price Rebound [Yahoo! Finance]

Sarepta Therapeutics, Inc.  (SRPT) 
Last sarepta therapeutics, inc. earnings: 2/26 04:05 pm Check Earnings Report
PDF Sarepta Therapeutics (SRPT) is back in focus after releasing early Phase 1/2 data for two investigational siRNA therapies, SRP-1001 and SRP-1003, targeting rare neuromu [Read more]